Search
Patexia Research
Case number 2018-1993

Amgen Inc. v. Coherus BioSciences Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 AMGEN INC. v. COHERUS BIOSCIENCES INC. [OPINION - PRECEDENTIAL] [precedential] (0)
Dec 18, 2019 67 CORRECTED REPLY BRIEF FILED for Amgen Inc. and Amgen Manufacturing Limited. Number of Pages: 30. Service: 12/10/2019 by email. [657581] [MJL] [Entered: 12/18/2019 03:23 PM] (39)
Dec 18, 2019 66 ORDER filed. Amgen's motion [65] is granted to the extent that ECF No. [42] will be sealed and the corrected non-confidential reply brief in Exhibit A will be entered separately on the docket. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [657578] [MJL] [Entered: 12/18/2019 03:19 PM] (2)
Dec 10, 2019 65 MOTION of Appellants Amgen Inc. and Amgen Manufacturing Limited to Replace the File Attachment for Docket No. 42 with Exhibit A [Consent: unopposed]. Service: 12/10/2019 by email. [655373] [18-1993] [Jennifer Wu] [Entered: 12/10/2019 03:41 PM] (45)
Sep 4, 2019 64 Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [633175] [MJL] [Entered: 09/04/2019 04:53 PM] (2)
Aug 12, 2019 63 Bill of Costs for Appellee Coherus BioSciences Inc.. Service: 08/12/2019 by email. [627680] [18-1993] [Louis Fogel] [Entered: 08/12/2019 04:05 PM] (0)
Jul 29, 2019 62 JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [623945] [JAB] [Entered: 07/29/2019 09:10 AM] (2)
Jul 29, 2019 61 OPINION filed for the court by Reyna, Circuit Judge; Hughes, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. [623944] [JAB] [Entered: 07/29/2019 09:10 AM] (12)
May 30, 2019 60 **TEXT ONLY** ORDER granting motion to withdraw attorney Stephen A. Maniscalco [59] filed by Appellants Amgen Manufacturing Limited and Amgen Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [610427] [JAB] [Entered: 05/30/2019 01:11 PM] (0)
May 30, 2019 59 MOTION of Appellants Amgen Inc. and Amgen Manufacturing Limited to withdraw counsel Stephen A. Maniscalco [Consent: unopposed]. Service: 05/30/2019 by email. [610407] [18-1993] [Nicholas Groombridge] [Entered: 05/30/2019 11:54 AM] (5)
May 8, 2019 58 Submitted after ORAL ARGUMENT by Nicholas P. Groombridge for Amgen Manufacturing Limited and Amgen Inc. and Adam G. Unikowsky for Coherus BioSciences Inc. Panel: Judge: Reyna , Judge: Hughes , Judge: Stoll. [605785] [JCP] [Entered: 05/08/2019 10:46 AM] (0)
Apr 15, 2019 57 Response to notice of oral argument from the Appellee Coherus BioSciences Inc.. [600318] [18-1993] [Bradford Lyerla] [Entered: 04/15/2019 05:02 PM] (3)
Apr 15, 2019 56 Response to notice of oral argument from the Appellants Amgen Inc. and Amgen Manufacturing Limited. [600276] [18-1993] [Nicholas Groombridge] [Entered: 04/15/2019 04:18 PM] (3)
Mar 21, 2019 55 NOTICE OF ORAL ARGUMENT. Panel: 1905H. Case scheduled May 08, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 04/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [594730] [JAB] [Entered: 03/21/2019 04:32 PM] (2)
Jan 31, 2019 54 Notice from Appellants Amgen Inc. and Amgen Manufacturing Limited regarding conflicts with oral argument. Service: 01/31/2019 by email. [582544] [18-1993] [Nicholas Groombridge] [Entered: 01/31/2019 05:07 PM] (4)
Jan 31, 2019 53 Notice from Appellee Coherus BioSciences Inc. regarding conflicts with oral argument. None. Service: 01/31/2019 by email. [582489] [18-1993] [Adam Unikowsky] [Entered: 01/31/2019 03:46 PM] (2)
Jan 30, 2019 52 6 paper copies of the Confidential Joint Appendix [48] received from Appellants Amgen Inc. and Amgen Manufacturing Limited. [582075] [JCP] [Entered: 01/30/2019 12:48 PM] (0)
Jan 30, 2019 51 6 paper copies of the Confidential Reply Brief [43] received from Appellants Amgen Inc. and Amgen Manufacturing Limited. [582073] [JCP] [Entered: 01/30/2019 12:47 PM] (0)
Jan 25, 2019 50 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The notice of conflict with oral argument is due on or before 02/01/2019. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [581053] [JAL] [Entered: 01/25/2019 02:25 PM] (1)
Jan 25, 2019 49 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [581052] [JAL] [Entered: 01/25/2019 02:24 PM] (0)
Dec 19, 2018 48 MODIFIED ENTRY: CONFIDENTIAL JOINT APPENDIX FILED for Appellants Amgen Inc., Amgen Manufacturing Limited and Appellee Coherus BioSciences Inc. Number of Pages: 604. Service: 12/19/2018 by email. [573268]--[Edited 01/25/2019 by JAL - Compliance review complete] [Nicholas Groombridge] [Entered: 12/19/2018 05:01 PM] (0)
Dec 19, 2018 47 MODIFIED ENTRY: JOINT APPENDIX FILED for Appellants Amgen Inc., Amgen Manufacturing Limited and Appellee Coherus BioSciences Inc. Number of Pages: 605. Service: 12/19/2018 by email. [573264] --[Edited 01/25/2019 by JAL - Compliance review complete] [Nicholas Groombridge] [Entered: 12/19/2018 04:59 PM] (605)
Dec 19, 2018 46 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 12/19/2018 by email. [573219] [18-1993] [Nicholas Groombridge] [Entered: 12/19/2018 04:07 PM] (3)
Dec 19, 2018 45 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 12/19/2018 by email. [573216] [18-1993] [Nicholas Groombridge] [Entered: 12/19/2018 04:05 PM] (3)
Dec 19, 2018 44 Amended Certificate of Interest for the Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 12/19/2018 by email. [572983] [18-1993] [Nicholas Groombridge] [Entered: 12/19/2018 11:17 AM] (3)
Dec 12, 2018 43 MODIFIED ENTRY: CONFIDENTIAL REPLY BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing Limited. Number of Pages: 30. Service: 12/12/2018 by email. [571432]--[Edited 01/25/2019 by JAL - Compliance review complete] [Nicholas Groombridge] [Entered: 12/12/2018 06:47 PM] (0)
Dec 12, 2018 42 MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing Limited. Number of Pages: 30. Service: 12/12/2018 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [571430] --[Edited 01/25/2019 by JAL - Compliance review complete]. This brief has been sealed and corrected. See Order No. [66] and Doc. No. [67]. [Nicholas Groombridge] [Entered: 12/12/2018 06:46 PM] (0)
Nov 8, 2018 41 6 paper copies of the Confidential Opening Response Brief [39] received from Appellee Coherus BioSciences Inc.. [563577] [CJF] [Entered: 11/08/2018 01:32 PM] (0)
Oct 31, 2018 40 BRIEF FILED for Appellee Coherus BioSciences Inc. [38]. Number of Pages: 44. Service: 10/31/2018 by email. [563340] [JB] [Entered: 11/07/2018 03:18 PM] (55)
Oct 31, 2018 39 CONFIDENTIAL BRIEF FILED for Appellee Coherus BioSciences Inc. [37]. Number of Pages: 44. Service: 10/31/2018 by email. The paper copies of the brief should be received by the court on or before 11/15/2018. [563335] [JB] [Entered: 11/07/2018 03:12 PM] (0)
Oct 31, 2018 38 TENDERED from Appellee Coherus BioSciences Inc.. Title: RESPONSE BRIEF. Service: 10/31/2018 by email. [561806] [18-1993] [Bradford Lyerla] [Entered: 10/31/2018 08:58 PM] (55)
Oct 31, 2018 37 TENDERED from Appellee Coherus BioSciences Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 10/31/2018 by email. [561805] [18-1993] [Bradford Lyerla] [Entered: 10/31/2018 08:54 PM] (0)
Sep 24, 2018 36 **TEXT ONLY** ORDER granting motion to extend time to file brief [35] filed by Appellants Amgen Manufacturing Limited and Amgen Inc. Reply brief is due 12/12/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [551974] [JB] [Entered: 09/24/2018 10:23 AM] (0)
Sep 20, 2018 35 MOTION of Appellants Amgen Inc. and Amgen Manufacturing Limited to extend the time to 12/12/2018 to file the Reply Gray Brief. [Consent: unopposed]. Service: 09/20/2018 by email. [551448] [18-1993] [Nicholas Groombridge] [Entered: 09/20/2018 03:15 PM] (10)
Sep 19, 2018 34 **TEXT ONLY** ORDER granting motion to extend time to file appellee's response brief ([32], corrected by [33]) filed by Appellee Coherus BioSciences Inc. The brief is due 10/31/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [551153] [MJL] [Entered: 09/19/2018 05:38 PM] (0)
Sep 18, 2018 33 MOTION of Appellee Coherus BioSciences Inc. to extend the time to 10/31/2018 to file the Appellee Brief. [Consent: unopposed]. Service: 09/18/2018 by email. [550712] [18-1993] [Adam Unikowsky] [Entered: 09/18/2018 01:15 PM] (8)
Sep 12, 2018 32 MOTION of Appellee Coherus BioSciences Inc. to extend the time to 10/31/2018 to file the Appellee Brief. [Consent: not addressed]. Service: 09/12/2018 by email. [549296] [18-1993] [Adam Unikowsky] [Entered: 09/12/2018 06:17 PM] (8)
Aug 27, 2018 31 6 paper copies of the Confidential Opening Brief [29] received from Appellants Amgen Inc. and Amgen Manufacturing Limited. [545491] [CJF] [Entered: 08/27/2018 10:21 AM] (0)
Aug 20, 2018 30 BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing Limited [28]. Number of Pages: 54. Service: 08/20/2018 by email. The paper copies of the confidential brief should be received by the court on or before 08/30/2018. Appellee Coherus BioSciences Inc. brief is due 10/01/2018. [545029] [CMP] [Entered: 08/23/2018 03:45 PM] (112)
Aug 20, 2018 29 CONFIDENTIAL BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing Limited [27]. Number of Pages: 54. Service: 08/20/2018 by email. The paper copies of the confidential brief should be received by the court on or before 08/30/2018. [545026] [CMP] [Entered: 08/23/2018 03:43 PM] (0)
Aug 20, 2018 28 TENDERED from Appellants Amgen Inc. and Amgen Manufacturing Limited. Title: OPENING BRIEF. Service: 08/20/2018 by email. [544204] [18-1993] [Nicholas Groombridge] [Entered: 08/20/2018 11:25 PM] (112)
Aug 20, 2018 27 TENDERED from Appellants Amgen Inc. and Amgen Manufacturing Limited. Title: CONFIDENTIAL OPENING BRIEF Service: 08/20/2018 by email. [544203] [18-1993] [Nicholas Groombridge] [Entered: 08/20/2018 11:21 PM] (0)
Jul 18, 2018 26 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [536853] [CMP] [Entered: 07/18/2018 03:24 PM] (0)
Jul 13, 2018 25 **TEXT ONLY** ORDER granting motion to extend time to file brief [24] filed by Appellants Amgen Manufacturing Limited and Amgen Inc.. Brief is due 08/20/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [535869] [CMP] [Entered: 07/13/2018 02:57 PM] (0)
Jul 13, 2018 24 MOTION of Appellants Amgen Inc. and Amgen Manufacturing Limited to extend the time to 08/20/2018 to file the Opening Brief. [Consent: unopposed]. Service: 07/13/2018 by email. [535762] [18-1993] [Nicholas Groombridge] [Entered: 07/13/2018 12:09 PM] (10)
Jul 3, 2018 23 Entry of appearance for Louis E. Fogel as of counsel for Appellee Coherus BioSciences Inc.. Service: 07/03/2018 by email. [533501] [18-1993] [Louis Fogel] [Entered: 07/03/2018 02:41 PM] (2)
Jun 15, 2018 22 Entry of appearance for Susan O'Brien as of counsel for Appellee Coherus BioSciences Inc.. Service: 06/15/2018 by email. [530049] [18-1993] [Bradford Lyerla] [Entered: 06/15/2018 05:58 PM] (2)
Jun 4, 2018 21 Docketing Statement for the Appellee Coherus BioSciences Inc.. Service: 06/04/2018 by email. [526784] [18-1993] [Bradford Lyerla] [Entered: 06/04/2018 08:43 PM] (3)
Jun 4, 2018 20 Certificate of Interest for the Appellee Coherus BioSciences Inc.. Service: 06/04/2018 by email. [526783] [18-1993] [Bradford Lyerla] [Entered: 06/04/2018 08:41 PM] (3)
Jun 4, 2018 19 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Jennifer Gordon (entry of appearance [8]) is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [526732] [CMP] [Entered: 06/04/2018 04:03 PM] (0)
Jun 4, 2018 18 Entry of appearance for Aaron A. Barlow as of counsel for Appellee Coherus BioSciences Inc.. Service: 06/04/2018 by email. [526702] [18-1993] [Aaron Barlow] [Entered: 06/04/2018 03:26 PM] (2)
Jun 4, 2018 17 Entry of appearance for Adam G. Unikowsky as of counsel for Appellee Coherus BioSciences Inc.. Service: 06/04/2018 by email. [526699] [18-1993] [Adam Unikowsky] [Entered: 06/04/2018 03:22 PM] (2)
Jun 4, 2018 16 Entry of appearance for Bradford P. Lyerla as principal counsel for Appellee Coherus BioSciences Inc.. Service: 06/04/2018 by email. [526688] [18-1993] [Bradford Lyerla] [Entered: 06/04/2018 03:14 PM] (2)
Jun 4, 2018 15 Docketing Statement for the Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 06/04/2018 by email. [526559] [18-1993] [Nicholas Groombridge] [Entered: 06/04/2018 11:27 AM] (5)
May 31, 2018 14 Certificate of Compliance with Fed. R. App. P. 10(b) [The Transcript of Proceedings] for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525986] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:17 PM] (2)
May 31, 2018 13 Certificate of Interest for the Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525982] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:15 PM] (2)
May 31, 2018 12 Entry of appearance for Golda Lai as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525979] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:13 PM] (2)
May 31, 2018 11 Entry of appearance for Jacob T. Whitt as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525976] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:12 PM] (2)
May 31, 2018 10 Entry of appearance for Stephen A. Maniscalco as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525974] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:10 PM] (2)
May 31, 2018 9 Entry of appearance for Peter Sandel as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525972] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:08 PM] (2)
May 31, 2018 8 Entry of appearance for Jennifer Gordon as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525971] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:06 PM] (2)
May 31, 2018 7 Entry of appearance for Jennifer H. Wu as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525970] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:05 PM] (2)
May 31, 2018 6 Entry of appearance for Kimberlin L. Morley as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525968] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:03 PM] (2)
May 31, 2018 5 Entry of appearance for Lois M. Kwasigroch as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525967] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 04:01 PM] (2)
May 31, 2018 4 Entry of appearance for Wendy A. Whiteford as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525963] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 03:58 PM] (2)
May 31, 2018 3 Entry of appearance for Nicholas Groombridge as principal counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 05/31/2018 by email. [525960] [18-1993] [Nicholas Groombridge] [Entered: 05/31/2018 03:56 PM] (2)
May 21, 2018 2 Sealed or confidential document received [US District Court for the District of Delaware, March 26, 2018, Memorandum Order]. Service: 05/21/2018 by email. [523329] [CMP] [Entered: 05/21/2018 03:20 PM] (0)
May 21, 2018 1 Appeal docketed. Received: 05/18/2018. [523318]Entry of Appearance due 06/04/2018. Certificate of Interest is due on 06/04/2018. Docketing Statement due 06/04/2018. Appellant's brief is due 07/20/2018. [CMP] [Entered: 05/21/2018 03:11 PM] (16)
Menu